BioSig Completes $1.1 Billion Merger With Streamex For Blockchain Commodity Tokenization

BioSig Technologies, a Nasdaq-listed firm, has completed its merger with Streamex Exchange Corporation in the Bahamas on July 8, 2025. This strategic move is aimed at advancing efforts in blockchain-based commodity tokenization, a significant development in the $142 trillion global commodity market. The merger includes a $1.1 billion financier-backed agreement, designed to enhance liquidity and transparency in the sector. Investors have reacted positively to this strategic move, which is expected to alter the dynamics of the commodity market.

The merger brings together the expertise and resources of both companies, with Henry McPhie leading the new entity as CEO and Morgan Lekstrom as Chairman. The strategic financing arrangement includes a significant $1 billion in equity, with an initial disbursement of $75 million by October 7, 2025. This capital injection is aimed at bolstering initiatives in tokenizing commodities and optimizing gold-backed treasury protocols. The merger is perceived as transformative for advancing BioSig’s business scope, with key leadership coming from Streamex.

Anthony Amato, former CEO of BioSig, highlighted the growth potential unlocked by this merger, stating that it represents a historic opportunity for growth. The enhanced financial resources are expected to drive the development of integrated blockchain solutions, providing new trails for commodity management. Stakeholder feedback emphasizes a cautious optimism with potential indirect benefits for cryptocurrencies, given their role as a base layer for tokenization projects.

The merger and financing deal underscore the growing interest in tokenized assets and the potential for blockchain technology to disrupt traditional financial markets. By securing $1.1 billion in growth financing, BioSig and Streamex are well-positioned to capitalize on this emerging trend and establish themselves as leaders in the tokenization space. The companies' focus on gold-backed tokens reflects their strategic vision to create a secure and transparent platform that meets the evolving needs of investors in the digital age.

The $1.1 billion financing deal is structured to support the development and launch of the gold-backed tokenized commodities platform. The first part of the deal, worth $75 million, is expected to close soon, marking a significant milestone in the companies' journey. The remaining funds will be deployed over the next 24 months to support ongoing operations, research and development, and strategic acquisitions. The merger between BioSig and Streamex is a pivotal move that underscores the companies' commitment to innovation in the financial technology sector.

By combining their expertise and resources, the merged entity aims to become a leading player in the tokenization of real-world assets (RWAs). This initiative is expected to revolutionize the way commodities are traded and managed, offering greater liquidity, transparency, and security to investors. The platform will enable the issuance and trading of digital tokens backed by physical gold, providing investors with a new asset class that combines the stability of gold with the efficiency of digital assets. This innovative approach is expected to attract a wide range of investors, from institutional players to retail participants, seeking to diversify their portfolios and gain exposure to precious metals.